Pentwater Capital Management LP Q3 2020 Filing

Filed November 16, 2020

Portfolio Value

$7.7B

Holdings

219

Report Date

Q3 2020

Filing Type

13F-HR

All Holdings (219 positions)

#StockSharesValue% PortfolioType
201
ADCTADC THERAPEUTICS SA
10,000$330.0M4.28%
202
PINGUSDPING IDENTITY HLDG CORP
10,500$328.0M4.25%
203
XPEVXPENG INC
15,900$319.0M4.14%
204
BSYBENTLEY SYS INC
10,000$314.0M4.07%
205
ROADCONSTRUCTION PARTNERS INC
16,900$308.0M3.99%
206
CHWYCHEWY INC
5,000$274.0M3.55%
207
LYRALYRA THERAPEUTICS INC
23,800$266.0M3.45%
208
RPTXREPARE THERAPEUTICS INC
8,500$262.0M3.40%
209
CSTLCASTLE BIOSCIENCES INC
5,000$257.0M3.33%
210
VASTA PLATFORM LTD
15,000$231.0M3.00%
211
BCYCBICYCLE THERAPEUTICS PLC
12,000$229.0M2.97%
212
TRANSLATE BIO INC
15,000$204.0M2.65%
213
ORICORIC PHARMACEUTICALS INC
8,000$200.0M2.59%
214
IPOAGBPVIRGIN GALACTIC HOLDINGS INC
10,000$192.0M2.49%
215
CENTOGENE N V
20,000$189.0M2.45%
216
VIA OPTRONICS AG
14,900$133.0M1.72%
217
EVOFEM BIOSCIENCES INC
50,000$118.0M1.53%
218
APY1EURCHAMPIONX CORPORATION
10,000$80.0M1.04%
219
DRAGONEER GROWTH OPPORTUNITIES CORP
1,000$12.0M0.16%
PreviousPage 3 of 3